Weakened profitability caused by high rate of cost to sales

Published: 2016-12-16 13:38:25

Updated: 2016-12-16 13:38:25

It was criticized pharmaceutical companies’ profitability is getting weaker as the rate of cost to sales is increasing due to their increased sales of merchandise.

According to the Yakup Shinmoon’s(www.yakup.com) analysis result of KOSPI and KOSDAQ listed pharmaceutical companies’ 2016 3rd quarter performance reports, their average rate of cost to selling price was 59.3%.

Compared to the rate...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.